Skip to Main Content

Paper Details

Discovery of OICR12694: A Novel, Potent, Selective, and Orally Bioavailable BCL6 BTB Inhibitor.
ACS Med Chem Lett
3
2023
Author NameAffiliation
Michael PrakeschOntario Institute for Cancer Research, University Avenue
Richard MarcellusOntario Institute for Cancer Research, University Avenue
Brigitte L Th??riaultOntario Institute for Cancer Research, University Avenue
Ahmed AmanOntario Institute for Cancer Research, University Avenue
Ahmed AmanLeslie Dan Faculty of Pharmacy, University of Toronto
David UehlingOntario Institute for Cancer Research, University Avenue
Rima Al-AwarOntario Institute for Cancer Research, University Avenue
Rima Al-AwarUniversity of Toronto
Rima Al-AwarUniversity of Toronto
Methvin IsaacOntario Institute for Cancer Research, University Avenue
  • 1 - 10

Datasets

Release 1.2